Latest OHSU Knight Cancer Institute Stories
A constellation of defective proteins suspected in causing a malfunction in the body’s ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range of ovarian cancer patients, an Oregon Health & Science University Knight Cancer Institute study found.
Mutations that are found in stem cells could be causing some breast cancers to develop and may be the reason the disease recurs.
Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth.
OHSU Knight Cancer Institute findings prompt Phase II clinical trial for high-risk prostate cancer patients.
Oregon Health & Science University today announced that Philip H. and Penny Knight have pledged to give $100 million to the OHSU Cancer Institute.
- A woman chauffeur.
- A woman who operates an automobile.